News

Genmab Unveils Late-Stage Data Ahead of ASCO 2025 Meeting

Genmab Unveils Late-Stage Data Ahead of ASCO 2025 Meeting

Overview of Upcoming ASCO 2025 Presentations

Genmab A/S (NASDAQ: GMAB) is set to showcase significant advancements from its late-stage oncology portfolio at the upcoming American Society of Clinical Oncology (ASCO) Annual Meeting. This prestigious event will be held in a major city, highlighting cutting-edge research aimed at improving cancer treatments.

Groundbreaking Research on Rinatabart Sesutecan

Among the highlights is the inaugural presentation of *rinatabart sesutecan (Rina-S)*, which is a novel antibody-drug conjugate (ADC) targeting folate receptor-alpha (FR?). It is currently under investigation for treating patients with recurrent or advanced endometrial cancer. The preliminary findings from this Phase 1/2 clinical trial promise to shed light on its safety and effectiveness.

Significance of Rina-S in Endometrial Cancer

This innovative therapy is particularly notable as endometrial cancer is associated with rising mortality rates and limited treatment options. Dr. Judith Klimovsky, Executive Vice President and Chief Development Officer at Genmab, expressed optimism, remarking on the company's commitment to providing new therapeutic avenues for patients struggling with this form of cancer.

Long-Term Insights from Epcoritamab Studies

Genmab will also present long-term follow-up results from the Phase 1/2 EPCORE™ NHL-1 study, focusing on *epcoritamab* for patients diagnosed with relapsed/refractory diffuse large B-cell lymphoma (DLBCL). This bispecific antibody is administered subcutaneously, showcasing Genmab’s innovation in treating challenging lymphomas.

Importance of Epcoritamab

Epcoritamab has gained traction for its mechanism of action that engages T-cells during treatment, heralding a new wave of therapies in hematologic malignancies. The results shared during ASCO will detail the responses observed after two years, particularly illuminating how many patients remain in complete response.

Virtual Investor Update

As part of its ASCO presence, Genmab will host a virtual investor update on June 2, focusing on the data presented for Rina-S. This session will be webcast live, making it accessible to stakeholders eager to learn more about these promising findings.

Accessibility of Clinical Findings

All abstracts approved for display at ASCO will be available online, providing a comprehensive resource for healthcare professionals and researchers. These documents will include critical insights into both rinatabart sesutecan and epcoritamab, underscoring Genmab’s commitment to transparency in research and development.

Commitment to Innovation in Oncology

Genmab’s research is characterized by the use of advanced technologies aimed at developing differentiated antibody therapeutics. With a commitment to improving the lives of cancer patients, the company is leveraging decades of experience to usher in the next generation of cancer medications.

About Genmab

Founded in 1999 and headquartered in Copenhagen, Denmark, Genmab has built a strong reputation in the biotechnology field. Its focus has always been on innovative antibody therapeutics, and its ongoing collaborations with partners like AbbVie enhance its ability to bring scientific breakthroughs to the marketplace.

Genmab invites stakeholders to learn more about its endeavors by visiting its official website and engaging with its latest updates. With numerous clinical trials and research initiatives underway, the company's future looks promising.

Frequently Asked Questions

What is Genmab presenting at ASCO 2025?

Genmab will present new data from its oncology portfolio, specifically focusing on rinatabart sesutecan and epcoritamab.

What does Rina-S target?

Rina-S targets folate receptor-alpha (FR?) and is being evaluated for advanced endometrial cancer treatment.

When is the virtual investor update?

The virtual investor update is scheduled for June 2 at 4:00 PM CDT.

What is the significance of epcoritamab?

Epcoritamab has been developed as a treatment for relapsed/refractory DLBCL, engaging T-cells to enhance response in patients.

How can I access the abstracts presented at ASCO?

All approved abstracts will be available online via the ASCO Meeting Library after the presentations.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Sivers Moves Q3 Release to Accommodate U.S. Investors

Updated Category News Views 0

Thanksgiving has a nasty habit of turning perfectly ordinary earnings dates into ghost towns, and Sivers Semiconductors has sensibly stepped around that pothole. The company will publish its third-quarter 2026 interim report on Monday, November 30, rather than Thursday, November 26. That is not a strategy reset, a warning, or some grand corporate mystery. It is a calendar...

Continue Reading
RBI Heads to Morgan Stanley With Plenty to Explain

Updated Category News Views 63

Two executives, one New York stage, and a short calendar gap give Restaurant Brands International a clean chance to address investors without the usual blizzard of quarterly slides. Chief Executive Officer Josh Kobza and Chief Financial Officer Sami Siddiqui are scheduled for a fireside chat at Morgan Stanley's Global Consumer & Retail Conference on December 2, 2026, at...

Continue Reading
Cybersecurity's AI Tailwind Meets a Brutal Market Test

Updated Category News Views 89

Security software caught a bid while the rest of the tape was getting kicked down the stairs. That contrast is the whole story: investors saw Palo Alto Networks deliver a strong fiscal first quarter and raise its fiscal 2027 outlook, then decided cyber defense may be one of the few technology budgets companies cannot casually postpone. With AI helping attackers locate and...

Continue Reading
Prospera’s DFW Culture Win Matters Beyond the Plaque

Updated Category News Views 46

Employee survey ballots rarely make pulses race, but this one deserves more than a lazy shrug. Prospera Financial Services has landed on The Dallas Morning News’ 2026 Top Workplaces DFW list for a second consecutive year, placing in the Top Small Workplaces category. For a boutique independent broker-dealer, that is not meaningless wall décor. The people doing the...

Continue Reading
Early Home Care Signals Families Should Not Ignore

Updated Category News Views 17

A pill organizer sitting untouched can say more than a family conversation ever will. Jay Mann of Amada Senior Care in Richmond points to a hard truth in HelloNation's Nov. 20, 2026 article: the need for in-home support often arrives quietly, disguised as little breaks in routines that everybody would rather wave away. This is not a matter for armchair diagnosis, and...

Continue Reading
Epilepsy Campaign Puts Patient Voices Before Investors

Updated Category News Views 12

An epilepsy diagnosis can turn ordinary family routines into a maze overnight, which is why awareness work deserves more than the usual polite nod and a colored ribbon. Mediaplanet's national Epilepsy Awareness campaign, launched November 20, 2026, brings the subject into a USA TODAY print insert and related digital coverage during Epilepsy Awareness Month. That reach...

Continue Reading
MFB Bancorp Offering Puts Chicago Bank Conversion First

Updated Category News Views 86

A small Chicago thrift is asking investors to fund a corporate makeover, and the fine print matters more than the $10 sticker price. MFB Bancorp has commenced an offering tied to the planned conversion of Mutual Federal Bancorp, MHC from a mutual holding company structure into a stock holding company. This is not some high-growth bank story with a shiny new branch map. It...

Continue Reading
Pennsylvania Housing Finds Its October Holding Pattern

Updated Category News Views 56

Pennsylvania's October housing numbers have the uneasy stillness of a pond before somebody throws a rock. The statewide median sales price sat at $315,000, exactly where it was in September, while sales barely cleared 10,400 and available listings kept inching higher. Nothing in that mix screams boom or bust. Frankly, that is the point: a market can look calm on the...

Continue Reading
Sprocket’s GigaOm Leap Puts PTaaS Claims Under Scrutiny

Updated Category News Views 21

Security vendors love a shiny quadrant, but this one deserves more than the usual polite golf clap. Sprocket Security moved from Challenger and Outperformer in GigaOm’s 2025 Penetration Testing as a Service assessment to a Leader in the version 5 report released in 2026. That is a meaningful jump in a category where buyers are tired of annual testing reports that go...

Continue Reading
PBS Holiday Special Bets on Apollo 8, Music and Unity

Updated Category News Views 82

A moon mission, a 360-voice choir, and Christmas television make an unusual bundle, but that is precisely why this year’s Tabernacle Choir special has some real staying power. Peace on Earth: Christmas with The Tabernacle Choir is not trying to chase whatever noisy trend is chewing up attention this week. It is building a 90-minute holiday event around Apollo 8,...

Continue Reading

Top 5 Most Recently Viewed Articles

Experience the Magic of Winter Getaways at Inns of Monterey

Updated Category News Views 119

Celebrate Winter at Inns of Monterey Inns of Monterey invites you to celebrate the beauty of the winter season with a variety of memorable experiences. Each of our inns offers a unique charm, allowing guests to select a venue that aligns with their vision of a perfect cozy getaway. Whether you're planning a romantic dinner, a family vacation, or a fun retreat, we have...

Continue Reading
Guardian Metal Adjusts Warrant Share Admission Timeline

Updated Category News Views 117

Guardian Metal Adjusts Warrant Share Admission Timeline Guardian Metal Resources plc (LON:GMET/OTCQB:GMTLF) has recently announced a significant update regarding the timing of its warrant share admissions. A technical error has led the company to postpone the admission of 100,000 new shares on the AIM market. Initially anticipated for January 6, 2025, the new expected...

Continue Reading
ThinkCareBelieve Unpacks NATO's Role and Global Perceptions

Updated Category News Views 155

Understanding NATO's Global Impact In an insightful exploration of NATO's significance, ThinkCareBelieve delves into the complexities surrounding this military alliance. The article addresses common perceptions about NATO's role and challenges the narrative that it solely promotes peace. Instead, it raises critical questions about whether NATO may have an agenda that...

Continue Reading
Understanding Recent Options Trading Activity for UiPath

Updated Category News Views 79

Bearish Signals Emerge in UiPath's Options Trading The options trading scene often serves as a barometer for market mood, and right now, UiPath is giving off some serious bearish vibes. With recent trading actions unfolding, we've dug up 11 trades worth keeping an eye on—here's the lowdown. Market Sentiment Revealed Diving into trader behavior reveals a concerning...

Continue Reading
Entergy's Vision for Sustainable Growth in the Gulf South

Updated Category News Views 200

Entergy's Promoting Economic Growth in Gulf South Region At the recent annual meeting, Entergy's Chair and Chief Executive Officer Drew Marsh emphasized the transformative year the company had in 2024. He expressed optimism about the company's potential for continued growth and its commitment to the Gulf South region. Marsh highlighted the vital role Entergy plays in...

Continue Reading